AMBRISENTAN Pharmacologic Class Indexing
- Class set ID
- 3333f3fd-23cf-4d8a-b659-fb9c3658d58f
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| AMBRISENTAN TABLETS. These highlights do not include all the information needed to use AMBRISENTAN TABLETS safely and effectively. See full prescribing information for AMBRISENTAN TABLETS. AMBRISENTAN tablets, for oral use Initial U.S. Approval: 2007 | Golden State Medical Supply, Inc. | 20260127 | 3 |
| Ambrisentan (4051.F) | Veranova, L.P. | 20260106 | 7 |
| These highlights do not include all the information needed to use AMBRISENTAN TABLETS safely and effectively. See full prescribing information for AMBRISENTAN TABLETS. AMBRISENTAN tablets, for oral use Initial U.S. Approval: 2007 | Quallent Pharmaceuticals Health LLC | Zydus Lifesciences Limited | 20260105 | 4 |
| These highlights do not include all the information needed to use AMBRISENTAN TABLETS safely and effectively. See full prescribing information for AMBRISENTAN TABLETS. AMBRISENTAN tablets, for oral use Initial U.S. Approval: 2007 | Mylan Pharmaceuticals Inc. | 20251205 | 7 |
| These highlights do not include all the information needed to use AMBRISENTAN TABLETS safely and effectively. See full prescribing information for AMBRISENTAN TABLETS . AMBRISENTAN tablets, for oral use Initial U.S. Approval: 2007 | Apotex Corp. | 20251118 | 9 |
| These highlights do not include all the information needed to use AMBRISENTAN TABLETS safely and effectively. See full prescribing information for AMBRISENTAN TABLETS. AMBRISENTAN tablets, for oral use Initial U.S. Approval: 2007 | A-S Medication Solutions | 20251008 | 1 |
| These highlights do not include all the information needed to use AMBRISENTAN TABLETS safely and effectively. See full prescribing information for AMBRISENTAN TABLETS. AMBRISENTAN tablets, for oral use Initial U.S. Approval: 2007 | A-S Medication Solutions | 20251008 | 1 |
| These highlights do not include all the information needed to use LETAIRIS ® safely and effectively. See full prescribing information for LETAIRIS. Letairis (ambrisentan) tablets, for oral use Initial U.S. Approval: 2007 | Gilead Sciences, Inc. | 20250822 | 27 |
| These highlights do not include all the information needed to use AMBRISENTAN TABLETS safely and effectively. See full prescribing information for AMBRISENTAN TABLETS . AMBRISENTAN tablets, for oral use Initial U.S. Approval: 2007 | Actavis Pharma, Inc. | 20250530 | 19 |
| These highlights do not include all the information needed to use AMBRISENTAN TABLETS safely and effectively. See full prescribing information for AMBRISENTAN TABLETS. AMBRISENTAN tablets, for oral use Initial U.S. Approval: 2007 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited | 20250430 | 9 |
| These highlights do not include all the information needed to use AMBRISENTAN TABLETS safely and effectively. See full prescribing information for AMBRISENTAN TABLETS. AMBRISENTAN tablets, for oral use Initial U.S. Approval: 2007 | Cipla USA Inc. | CIPLA LIMITED PATALGANGA | 20250422 | 8 |
| These highlights do not include all the information needed to use AMBRISENTAN TABLETS safely and effectively. See full prescribing information for AMBRISENTAN TABLETS. AMBRISENTAN tablets, for oral use Initial U.S. Approval: 2007 | Aurobindo Pharma Limited | APL HEALTHCARE LIMITED | 20250421 | 2 |
| These highlights do not include all the information needed to use AMBRISENTAN TABLETS safely and effectively. See full prescribing information for AMBRISENTAN TABLETS. AMBRISENTAN tablets, for oral use Initial U.S. Approval: 2007 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 20250415 | 10 |
| AMBRISENTAN Tablets | Zydus Lifesciences Limited | 20241125 | 10 |
| These highlights do not include all the information needed to use AMBRISENTAN TABLETS safely and effectively. See full prescribing information for AMBRISENTAN TABLETS. AMBRISENTAN Tablets, for oral use Initial U.S. Approval: 2007 | Sigmapharm Laboratories, LLC | 20230110 | 7 |